In vitro activity of naftifine, a new antifungal agent.
AUTOR(ES)
Georgopoulos, A
RESUMO
Naftifine exhibits an interesting in vitro spectrum of activity against dermatophytes (38 strains; minimal inhibitory concentration [MIC] range 0.1 to 0.2 microgram/ml), aspergilli (6 strains; MIC range, 0.8 to 12.5 microgram/ml), Sporothrix schenckii (2 strains; MICs, 0.8 and 1.5 microgram/ml), and yeasts of the genus Candida (77 strains; MIC range, 1.5 to greater than 100 microgram/ml). Its degree of efficacy is unaffected by the organism density in the test medium, and it is primarily fungicidal against dermatophytes as well as yeasts. Its in vitro efficacy is pH dependent and rises with increasing pH values.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=181441Documentos Relacionados
- In vitro activity of ME1401, a new antifungal agent.
- In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.
- In vitro and in vivo antifungal activities of D0870, a new triazole agent.
- Comparative in vitro activity of SM7338, a new carbapenem antimicrobial agent.
- Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent.